Clearside Biomedical Inc buy klostergang
Start price
22.02.19
/
50%
€1.37
Target price
04.11.21
€3.16
Performance (%)
183.73%
End price
17.06.21
€3.89
Summary
This prediction ended on 17.06.21 with a price of €3.89. The BUY prediction by klostergang for Clearside Biomedical Inc saw massive gains of 183.73%. klostergang has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Clearside Biomedical Inc | -6.557% | -6.557% | 11.765% | -49.333% |
| iShares Core DAX® | 0.805% | 2.118% | 15.587% | 16.559% |
| iShares Nasdaq 100 | 1.995% | 4.071% | 28.811% | 56.196% |
| iShares Nikkei 225® | 1.264% | -2.374% | 3.374% | 4.271% |
| iShares S&P 500 | 1.637% | 2.287% | 24.187% | 46.895% |
Comments by klostergang for this prediction
In the thread Clearside Biomedical Inc diskutieren
CLSD as the FDA accepted its marketing application
The FDA accepted its marketing application seeking approval for XIPERE (triamcinolone acetonide ophthalmic solution) for Suprachoroidal Injection (area in the posterior segment of the eye) for the treatment of macular edema associated with uveitis.
The agency's action date is October 19 (under the 505(b)(2) pathway).
Es gibt keinen Handelsplatz